You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses

 

Online download statistics by month:

Online download statistics by month: January 2023 to October 2025

AbstractFullPdf
Jan 2023930943281
Feb 2023398402160
Mar 202323923977
Apr 202317117264
May 202314414443
Jun 202314214244
Jul 202313113369
Aug 202313413418
Sep 2023979739
Oct 202310410445
Nov 202315915940
Dec 2023969733
Jan 2024585726
Feb 2024595926
Mar 2024959573
Apr 202411311434
May 2024858632
Jun 2024484724
Jul 202410310428
Aug 2024878430
Sep 2024919119
Oct 2024919133
Nov 2024959737
Dec 202410911038
Jan 202511511641
Feb 202515115228
Mar 2025747431
Apr 2025989836
May 2025757544
Jun 2025505128
Jul 2025110
Oct 2025550
Total434843731521